U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457281) titled 'GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Ce... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457619) titled 'Coblation Tonsillectomy Versus Cold Dissection Tonsillectomy' on Feb. 26. Brief Summary: ... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458607) titled 'UNC Tobacco Convenience Store Study' on March 04. Brief Summary: The main purpose of this... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458906) titled 'DLL3-Targeted PET/CT in Neuroendocrine Carcinoma' on Jan. 18. Brief Summary: The objectiv... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458347) titled 'A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors Wit... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458776) titled 'Effects of Muscle Energy Technique and Pilates Exercises on Pain and Physical Function in ... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457840) titled 'Integrating AI Predictions With Clinician Expertise' on Feb. 24. Brief Summary: Optimizin... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457060) titled 'Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactiva... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07459062) titled 'Spectral Cancer Tissue Recognition - I' on March 03. Brief Summary: This analytical perfo... Read More
U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07459543) titled 'A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combin... Read More